Open source license allows people to commercialize products based on the procedure. All that is required is that improvements to the technique itself be shared with all others users.
Maybe the most -yet- interesting project is TransBacter, the project which focuses on the use of bacteria outside the genus Agrobacterium for gene transfer to plants. Most of patents in that field are property of Monsanto, the dominant patent holder, who says, “open source biotech seems to complement, not threaten, our business model”.
Hope that does not mean : Monsanto will improve is own technique with open source biotech !
The agricultural firm makes already people eat shit thanks to its own patents, how will be good the shit with stolen open source technique ?
See more on
bioforge.net
Science Commons
Nature.com
The Economist | Science & Technology
